Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00440024 · ClinicalTrials.gov registry record · NA
The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00440024 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 40 participants.
The verdict
NCT00440024, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Sun-damaged skin, caused by chronic exposure to ultraviolet (UV) light, is characterized by features such as wrinkling, uneven skin color, roughness and brown spots. An effective treatment for sun-damage that is commonly prescribed is topical retinoic acid (RA). However, the major drawback of topical RA use has been frequently observed irritation characterized by redness, dry skin and severe itching. In this study, we examine whether a daily skin care regimen comprised of an ultra mild cleanser and an effective moisturizer can help improve tolerance to RA treatment.
Interventions
- DRUG Tazorac
- DRUG Dove Mild Cleanser
- DRUG Dove Facial Moisturizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00440024
The ClinicalTrials.gov registry entry for NCT00440024 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Tazorac is the first listed.
NCT00440024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00440024 about?
NCT00440024 is a clinical study titled "The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance". Sun-damaged skin, caused by chronic exposure to ultraviolet (UV) light, is characterized by features such as wrinkling, uneven skin color, roughness and brown spots. An effective treatment for sun-damage that is commonly prescribed is topical retinoic acid (RA). However, the major drawback of topica...
What is the current status of trial NCT00440024?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-02. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00440024?
The interventions under investigation include: Tazorac (DRUG), Dove Mild Cleanser (DRUG), Dove Facial Moisturizer (DRUG).
Who is sponsoring clinical trial NCT00440024?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.